Cell-specific systemic immune signatures associated with treatment burden in neovascular age-related macular degeneration

Authors

Joseph B Lin, Washington University School of Medicine in St. Louis
Andrea Santeford, Washington University School of Medicine in St. Louis
Darksha Usmani, Washington University School of Medicine in St. Louis
Aaditya V Shah, Washington University School of Medicine in St. Louis
Philip A Ruzycki, Washington University School of Medicine in St. Louis
Rajendra S Apte, Washington University School of Medicine in St. Louis

Journal

Ophthalmology Science

Publication Date

3-1-2024

Volume

4

Issue

2

First Page

100410

Document Type

Open Access Publication

DOI

10.1016/j.xops.2023.100410

Rights and Permissions

Lin JB, Santeford A, Usmani D, Shah AV, Ruzycki PA, Apte RS. Cell-specific Systemic Immune Signatures Associated with Treatment Burden in Neovascular Age-related Macular Degeneration. Ophthalmol Sci. 2023 Oct 11;4(2):100410. doi: 10.1016/j.xops.2023.100410. Copyright 2023 by the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).

Recommended Citation

Lin, Joseph B; Santeford, Andrea; Usmani, Darksha; Shah, Aaditya V; Ruzycki, Philip A; and Apte, Rajendra S, "Cell-specific systemic immune signatures associated with treatment burden in neovascular age-related macular degeneration." Ophthalmology Science. 4, 2. 100410 (2024).
https://digitalcommons.wustl.edu/oa_4/4567

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.